100 related articles for article (PubMed ID: 15970648)
1. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors.
Crudden G; Loesel R; Craven RJ
Tumour Biol; 2005; 26(3):142-6. PubMed ID: 15970648
[TBL] [Abstract][Full Text] [Related]
2. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs.
Crudden G; Chitti RE; Craven RJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):448-55. PubMed ID: 16234411
[TBL] [Abstract][Full Text] [Related]
3. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells.
Hand RA; Craven RJ
J Cell Biochem; 2003 Oct; 90(3):534-47. PubMed ID: 14523988
[TBL] [Abstract][Full Text] [Related]
4. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51.
Craven RJ; Mallory JC; Hand RA
J Biol Chem; 2007 Dec; 282(50):36543-51. PubMed ID: 17954932
[TBL] [Abstract][Full Text] [Related]
5. Cloning and tissue expression of two putative steroid membrane receptors.
Gerdes D; Wehling M; Leube B; Falkenstein E
Biol Chem; 1998 Jul; 379(7):907-11. PubMed ID: 9705155
[TBL] [Abstract][Full Text] [Related]
6. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
Ahmed IS; Chamberlain C; Craven RJ
Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
[TBL] [Abstract][Full Text] [Related]
7. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
Rohe HJ; Ahmed IS; Twist KE; Craven RJ
Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.
Ahmed IS; Rohe HJ; Twist KE; Mattingly MN; Craven RJ
J Pharmacol Exp Ther; 2010 May; 333(2):564-73. PubMed ID: 20164297
[TBL] [Abstract][Full Text] [Related]
9. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.
Hughes AL; Powell DW; Bard M; Eckstein J; Barbuch R; Link AJ; Espenshade PJ
Cell Metab; 2007 Feb; 5(2):143-9. PubMed ID: 17276356
[TBL] [Abstract][Full Text] [Related]
10. PGRMC2, a yet uncharacterized protein with potential as tumor suppressor, migration inhibitor, and regulator of cytochrome P450 enzyme activity.
Wendler A; Wehling M
Steroids; 2013 Jun; 78(6):555-8. PubMed ID: 23276631
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines.
Jiang JG; Fu XN; Chen CL; Wang DW
Ai Zheng; 2009 Feb; 28(2):93-6. PubMed ID: 19550113
[TBL] [Abstract][Full Text] [Related]
12. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines.
Ku JL; Park SC; Kim KH; Jeon YK; Kim SH; Shin YK; Noh DY; Im SA; Bang YJ; Han W; Kim WH; Park JG
Int J Oncol; 2013 Dec; 43(6):2073-81. PubMed ID: 24141649
[TBL] [Abstract][Full Text] [Related]
14. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling.
Zhu X; Han Y; Fang Z; Wu W; Ji M; Teng F; Zhu W; Yang X; Jia X; Zhang C
Oncol Rep; 2013 Nov; 30(5):2488-94. PubMed ID: 23970345
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner.
Oda S; Nakajima M; Toyoda Y; Fukami T; Yokoi T
Drug Metab Dispos; 2011 Nov; 39(11):2057-65. PubMed ID: 21825115
[TBL] [Abstract][Full Text] [Related]
16. P450 enzyme expression patterns in the NCI human tumor cell line panel.
Yu LJ; Matias J; Scudiero DA; Hite KM; Monks A; Sausville EA; Waxman DJ
Drug Metab Dispos; 2001 Mar; 29(3):304-12. PubMed ID: 11181500
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
19. A helping hand for cytochrome p450 enzymes.
Debose-Boyd RA
Cell Metab; 2007 Feb; 5(2):81-3. PubMed ID: 17276348
[TBL] [Abstract][Full Text] [Related]
20. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
